11-02-2025
PureHealth sees profits soar on $7bn revenue as hospital business up 87%
PureHealth has recorded strong revenue and profit growth in year of major expansion
PureHealth Holding recorded a strong revenue increase of 58 per cent year-on-year to AED25.8bn ($7bn), last year according to official figures.
The sharp increase was driven by robust growth across its core segments, including Hospitals, Insurance and Procurement; and was further strengthened by the successful integration of strategic acquisitions.
The Group's strong performance reflected positively on profitability, with EBITDA growing 69 per cent year-on-year to AED4.1bn ($1.1bn) and net profit increasing by 78 per cent year-on-year to AED1.7bn ($463m) in 2024.
PureHealth results
Hamad Al Hammadi, Chairman of PureHealth, said: 'PureHealth's exceptional performance in 2024 is a testament to our strategic vision, commitment to innovation, and the trust our partners and stakeholders place in our healthcare ecosystem.
'This year, we significantly expanded our global presence with key acquisitions, strengthened our operational capabilities, and advanced our mission to redefine healthcare excellence.
'As we move forward, we remain focused on our global expansion and value creation for our shareholders.'
Shaista Asif, Group Chief Executive Officer at PureHealth, said: '2024 has been a transformative year for PureHealth, marked by strategic expansion, operational excellence, and innovation – where we pushed boundaries and redefined healthcare possibilities.
'With the acquisition of Circle Health Group in the UK, we extended our world-class care beyond borders, while the integration of Sheikh Shakhbout Medical City (SSMC) reinforced our expertise in complex, life-saving treatments.
'Every decision we make is about impact on patients, communities, and the future of medicine. As we enter 2025, we remain focused on expanding specialised services, leveraging AI to enhance operational efficiency and advance predictive and personalised care, while accelerating international growth.
'With a disciplined investment approach, we are committed to transforming the assets we manage, ensuring they create lasting value and impact for all stakeholders, while delivering healthcare excellence globally.'
PureHealth's solid performance was driven primarily by the Group's hospitals segment, which saw an 87 per cent year-on-year increase in revenue to AED19.7bn ($5.4bn) on the back of strong patient volume growth and the expansion of the Group's medical services across its network in 2024.
A combination of initiatives, along with the Group's strategic acquisitions, have resulted in an expansion of PureHealth's global footprint as well as enhanced operational capabilities, and drove a patient interaction increase across the Group's UAE and UK assets of 66 per cent to 9.9 million in 2024.
Additionally, bed capacity increased to approximately 4,900 beds, nearly doubling year-on-year, meanwhile, outpatient, inpatient, and emergency volumes grew by 72 per cent, 24 per cent and 31 per cent, respectively, in 2024, across its UAE and UK assets.
On the organic growth front, PureHealth significantly expanded its clinical capabilities and improved patient access in 2024 by implementing strategic initiatives covering service line expansion, infrastructure development, specialist diversification, and extended accessibility.
Other segments of the business experienced strong growth in 2024. The Insurance Segment saw a 17 per cent year-on-year revenue increase to almost AED6.9bn ($1.9bn), driven by a 6 per cent rise in active members to more than 3 million and a 24 per cent surge in gross written premiums.
The Procurement Segment recorded a 27 per cent increase in revenue, reaching AED5.2bn ($1.4bn), fuelled by an expanding client base, strategic growth in diagnostics and medical devices, and an expansion of the pharmaceutical and diabetes divisions.
The Diagnostic Services Segment reported a revenue increase of around 1 per cent reaching AED1.1bn ($299m), with the uptick driven by an increase in patient footfall, the expansion of laboratory services, and a stronger adoption of preventative health screenings.
Meanwhile, the newly established Technology Segment, dedicated to driving digital transformation and enhancing AI and IT capabilities across the Group, contributed AED469m ($128m) in its first year.
PureHealth's strategy focuses on building a scalable equity platform that delivers complex healthcare services captures a greater share of the market, and achieves robust profitability.
At the same time, the Group is evolving into a future-ready organisation by harnessing digital technologies that will shape the next generation of healthcare.
To accelerate its global footprint, PureHealth is actively pursuing additional acquisitions, following its recent investments in key international markets.
The Group is also intensifying its commitment to technology and AI-driven solutions—ranging from predictive analytics for early disease detection to AI-powered personalised treatment plans, operational efficiencies and digital patient engagement tools.
